Home NDC 0591-2406-77 Ambrisentan
Product NDC 0591-2406
Requested package NDC 0591-2406-77
11-digit product format 005912406
Labeler code 0591
Product ID 0591-2406_67758125-7c3e-4b62-8cb3-e17d7f079322
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ambrisentan
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Actavis Pharma, Inc.
Application ANDA208252
Marketing category ANDA
Marketing start 2019-04-30
Substance AMBRISENTAN
Active strength 10 mg/1
Pharmacologic classes Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 11 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 27f29a85d7e4…1372111e901f…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208252-001 AMBRISENTAN AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 A208252-002 AMBRISENTAN AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A208252-001 AMBRISENTAN 5MG TABLET / ORAL AB 2019-03-28 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A208252-002 AMBRISENTAN 10MG TABLET / ORAL AB 2019-03-28 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Ambrisentan
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AMBRISENTAN 10 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination HW6NV07QEC Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 722116 Internal RxNorm lookup 722122 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0591-2406-30 Ambrisentan 30 in 1 BOTTLE TABLET, FILM COATED 30 19
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0591-2406 AMBRISENTAN TABLET, FILM COATED [ACTAVIS PHARMA, INC.] 16 Current NDC, Legacy NDC, 1 package rows 20250124_32549c43-f8ff-422c-b42d-ca0877e661cf.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Status 0591-2406-77 00591240677 52956 TABLET, FILM COATED in 1 CONTAINER (0591-2406-77) 07-AUG-24 Current